Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors
Robert S. Epstein, Matti Aapro, Upal Kunal Basu Roy, et al.
Advances in Therapy (2020) Vol. 37, Iss. 8, pp. 3606-3618
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?
Ralph V. Boccia, John A. Glaspy, Jeffrey Crawford, et al.
The Oncologist (2022) Vol. 27, Iss. 8, pp. 625-636
Open Access | Times Cited: 73
Myelosuppression Alleviation and Hematopoietic Regeneration by Tetrahedral‐Framework Nucleic‐Acid Nanostructures Functionalized with Osteogenic Growth Peptide
Tianxu Zhang, Mi Zhou, Dexuan Xiao, et al.
Advanced Science (2022) Vol. 9, Iss. 27
Open Access | Times Cited: 72
Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan
Rebecca S. Heist, Jacob Sands, Aditya Bardia, et al.
Cancer Treatment Reviews (2024) Vol. 125, pp. 102720-102720
Open Access | Times Cited: 16
First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With EGFR Exon 20 Insertion–Positive Metastatic Non–Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial
Pasi A. Jänne, Bin-Chao Wang, Byoung Chul Cho, et al.
Journal of Clinical Oncology (2025)
Closed Access | Times Cited: 2
Natural products targeting into cancer hallmarks: An update on caffeine, theobromine, and (+)-catechin
Francine Carla Cadoná, Rafael Ferreira Dantas, Gabriela Haas de Mello, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 62, Iss. 26, pp. 7222-7241
Closed Access | Times Cited: 60
Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies
Jared Weiss, Jerome H. Goldschmidt, Zoran Andrić, et al.
Clinical Lung Cancer (2021) Vol. 22, Iss. 5, pp. 449-460
Open Access | Times Cited: 58
The impact of myelosuppression on quality of life of patients treated with chemotherapy
Jeffrey Crawford, Dana Herndon, Katerina Gmitter, et al.
Future Oncology (2024) Vol. 20, Iss. 21, pp. 1515-1530
Open Access | Times Cited: 9
Grade ≥ 3 hematologic adverse events of immunotherapy in advanced NSCLC patients: a systematic review and meta-analysis
Shuang Wang, Meng‐Ting Cai, Yajun Xiong, et al.
European Journal of Clinical Pharmacology (2025)
Closed Access | Times Cited: 1
Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy‐induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials
Renata Ferrarotto, Ian C. Anderson, Balazs Medgyasszay, et al.
Cancer Medicine (2021) Vol. 10, Iss. 17, pp. 5748-5756
Open Access | Times Cited: 42
New trends in biotechnological applications of photosynthetic microorganisms
Anna Dawiec‐Liśniewska, Daria Podstawczyk, Anna Bastrzyk, et al.
Biotechnology Advances (2022) Vol. 59, pp. 107988-107988
Open Access | Times Cited: 36
Adjuvant role of Salvia miltiorrhiza bunge in cancer chemotherapy: A review of its bioactive components, health-promotion effect and mechanisms
Jiayan Huang, Jiaojiao Zhang, Chengtao Sun, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 117022-117022
Closed Access | Times Cited: 22
Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma
Wei Teng, Matthias Leisegang, Ming Xia, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 29
Selective Wee1 Inhibitors Led to Antitumor Activity In Vitro and Correlated with Myelosuppression
Satenig Guler, Maria C. DiPoto, Alejandro Crespo, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 5, pp. 566-576
Open Access | Times Cited: 11
Real-World Clinical Outcomes of Trilaciclib for the Prevention of Myelosuppression in Patients with Esophageal Cancer Undergoing Chemotherapy
Hui Chen, Junrong Yan, Zeyuan Liu, et al.
Current Oncology (2025) Vol. 32, Iss. 4, pp. 189-189
Open Access
Guilu Erxian Glue Alleviates Chemotherapy-induced Myelosuppression by Regulating Histone Methylation Level of p16 gene in Hematopoietic Stem Cells
Menglei Wang, J W Wang, Weizhi Lai, et al.
Deleted Journal (2025), pp. 200213-200213
Open Access
Real‐World Assessment of Trilaciclib for the Prevention of Chemoradiotherapy‐Induced Myelosuppression in Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study
Junrong Yan, Zeyuan Liu, Hui Chen, et al.
Cancer Medicine (2025) Vol. 14, Iss. 8
Open Access
Cancer Patients’ Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life
Robert S. Epstein, Upal Kunal Basu Roy, Matti Aapro, et al.
Patient Preference and Adherence (2021) Vol. Volume 15, pp. 453-465
Open Access | Times Cited: 24
Recent Advances of Material‐Decorated Photosynthetic Microorganisms and Their Aspects in Biomedical Applications
Songhan Liu, Hanyu Yang, Ming Yao Ho, et al.
Advanced Optical Materials (2023) Vol. 11, Iss. 11
Open Access | Times Cited: 10
Romiplostim in chemotherapy‐induced thrombocytopenia: A review of the literature
Gerald A. Soff, Hanny Al‐Samkari, Avi Leader, et al.
Cancer Medicine (2024) Vol. 13, Iss. 15
Open Access | Times Cited: 3
Chinese Herbal Medicine (JianPi-BuShen) and Completion Rate of Adjuvant Chemotherapy for Patients with Stage II and III Colon Cancer: A Randomized Clinical Trial
Lingyun Sun, Yun Xu, Nan Chen, et al.
European Journal of Cancer (2024) Vol. 213, pp. 115109-115109
Closed Access | Times Cited: 3
Burden of chemotherapy‐induced myelosuppression among patients with extensive‐stage small cell lung cancer: A retrospective study from community oncology practices
Lowell L. Hart, Augustina Ogbonnaya, Kristen Boykin, et al.
Cancer Medicine (2023) Vol. 12, Iss. 8, pp. 10020-10030
Open Access | Times Cited: 9
STS1 and STS2 Phosphatase Inhibitor Baicalein Enhances the Expansion of Hematopoietic and Progenitor Stem Cells and Alleviates 5-Fluorouracil-Induced Myelosuppression
Na Li, Yanhong Wang, Anqing Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2987-2987
Open Access | Times Cited: 8
Development of a Machine Learning-Based Prediction Model for Chemotherapy-Induced Myelosuppression in Children with Wilms’ Tumor
Mujie Li, Quan Wang, Peng Lu, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1078-1078
Open Access | Times Cited: 8
Discovery of Tetrahydropyrazolopyrazine Derivatives as Potent and Selective MYT1 Inhibitors for the Treatment of Cancer
Shaobin Wang, Chao Wang, Tingting Liu, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 1, pp. 420-432
Closed Access | Times Cited: 8
Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer
M. Dómine Gómez, Tibor Csöszi, Jana Jaal, et al.
International Journal of Cancer (2021) Vol. 149, Iss. 7, pp. 1463-1472
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top